Converging genetic and epigenetic drivers of paediatric acute lymphoblastic leukaemia identified by an information-theoretic analysis.


Journal

Nature biomedical engineering
ISSN: 2157-846X
Titre abrégé: Nat Biomed Eng
Pays: England
ID NLM: 101696896

Informations de publication

Date de publication:
04 2021
Historique:
received: 31 01 2019
accepted: 18 02 2021
pubmed: 17 4 2021
medline: 12 5 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

In cancer, linking epigenetic alterations to drivers of transformation has been difficult, in part because DNA methylation analyses must capture epigenetic variability, which is central to tumour heterogeneity and tumour plasticity. Here, by conducting a comprehensive analysis, based on information theory, of differences in methylation stochasticity in samples from patients with paediatric acute lymphoblastic leukaemia (ALL), we show that ALL epigenomes are stochastic and marked by increased methylation entropy at specific regulatory regions and genes. By integrating DNA methylation and single-cell gene-expression data, we arrived at a relationship between methylation entropy and gene-expression variability, and found that epigenetic changes in ALL converge on a shared set of genes that overlap with genetic drivers involved in chromosomal translocations across the disease spectrum. Our findings suggest that an epigenetically driven gene-regulation network, with UHRF1 (ubiquitin-like with PHD and RING finger domains 1) as a central node, links genetic drivers and epigenetic mediators in ALL.

Identifiants

pubmed: 33859388
doi: 10.1038/s41551-021-00703-2
pii: 10.1038/s41551-021-00703-2
pmc: PMC8370714
mid: NIHMS1675463
doi:

Substances chimiques

CCAAT-Enhancer-Binding Proteins 0
Core Binding Factor Alpha 2 Subunit 0
Oncogene Proteins, Fusion 0
TEL-AML1 fusion protein 0
UHRF1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-376

Subventions

Organisme : NIDDK NIH HHS
ID : DP1 DK119129
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA054358
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA065438
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG006282
Pays : United States

Références

Cell Rep. 2016 Feb 2;14(4):956-965
pubmed: 26804902
Nat Rev Cancer. 2018 Aug;18(8):471-484
pubmed: 29784935
Leukemia. 2016 Mar;30(3):728-39
pubmed: 26449661
Nature. 2008 Aug 7;454(7205):766-70
pubmed: 18600261
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nature. 2011 Mar 10;471(7337):235-9
pubmed: 21390130
Nat Genet. 2015 Jun;47(6):672-6
pubmed: 25961940
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
J Clin Invest. 2013 Jul;123(7):3099-111
pubmed: 23921123
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1930-5
pubmed: 19181846
Leukemia. 2013 Jun;27(6):1422-4
pubmed: 23168614
Nat Genet. 2016 Dec;48(12):1481-1489
pubmed: 27776115
Blood. 2011 Apr 7;117(14):3858-68
pubmed: 21321361
Semin Cancer Biol. 2013 Apr;23(2):109-15
pubmed: 23266653
Nat Rev Genet. 2016 May;17(5):284-99
pubmed: 26972587
BMC Bioinformatics. 2018 Mar 7;19(1):87
pubmed: 29514626
Leuk Res. 2012 Sep;36(9):1185-92
pubmed: 22748921
Cell Syst. 2017 Sep 27;5(3):251-267.e3
pubmed: 28957658
Nat Genet. 2015 Jul;47(7):746-56
pubmed: 26053498
Nat Commun. 2016 Jun 06;7:11790
pubmed: 27265895
Hematology Am Soc Hematol Educ Program. 2012;2012:389-96
pubmed: 23233609
Epigenomics. 2016 May;8(5):705-19
pubmed: 27104983
Nat Med. 2016 Jul;22(7):792-9
pubmed: 27322744
Semin Cell Dev Biol. 2017 Sep;69:172-182
pubmed: 28694114
Nucleic Acids Res. 2015 Mar 11;43(5):2590-602
pubmed: 25690899
BMC Genomics. 2011 Feb 09;12:102
pubmed: 21306619
Cell. 2012 Mar 16;148(6):1123-31
pubmed: 22424224
Blood. 2011 Nov 10;118(19):5218-26
pubmed: 21921043
Cancer Genet Cytogenet. 1996 Dec;92(2):111-5
pubmed: 8976366
J Ovarian Res. 2016 Jul 19;9(1):42
pubmed: 27431502
Immunity. 2008 Aug 15;29(2):217-27
pubmed: 18674933
Leukemia. 2012 Feb;26(2):265-70
pubmed: 21869842
J Clin Oncol. 2011 Feb 10;29(5):551-65
pubmed: 21220611
Sci Rep. 2015 Dec 10;5:18037
pubmed: 26659027
Epigenomics. 2016 Oct;8(10):1367-1387
pubmed: 27552300
Nature. 2012 Aug 23;488(7412):517-21
pubmed: 22842903
Nat Methods. 2014 Jul;11(7):740-2
pubmed: 24836921
N Engl J Med. 2015 Oct 15;373(16):1541-52
pubmed: 26465987
Oncogene. 2018 Sep;37(38):5221-5232
pubmed: 29849118
Nat Cancer. 2020 Nov;1(11):1066-1081
pubmed: 34079956
Tumour Biol. 2017 Feb;39(2):1010428317692205
pubmed: 28218043
Nat Genet. 2012 Nov;44(11):1207-14
pubmed: 23064413
Nat Commun. 2014 Mar 24;5:3469
pubmed: 24662245
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nature. 2018 Mar 15;555(7696):371-376
pubmed: 29489755
Nat Commun. 2015 Apr 20;6:6921
pubmed: 25891015
Nat Biotechnol. 2015 Apr;33(4):364-76
pubmed: 25690853
Oncotarget. 2019 Apr 30;10(32):3040-3050
pubmed: 31105884
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Tumour Biol. 2015 Nov;36(11):8887-93
pubmed: 26070868
Blood. 2010 Feb 11;115(6):1214-25
pubmed: 19965625
Cancer Biother Radiopharm. 2011 Apr;26(2):183-9
pubmed: 21539450
Cell. 2013 Mar 28;153(1):38-55
pubmed: 23540689
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Mol Cell. 2013 Mar 7;49(5):773-82
pubmed: 23473598
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Cancer Genet. 2011 Dec;204(12):687-91
pubmed: 22285022
Leuk Lymphoma. 2011 Jul;52(7):1215-21
pubmed: 21534874
BMC Bioinformatics. 2019 Apr 8;20(1):175
pubmed: 30961526
Pediatr Dermatol. 2018 Mar;35(2):e114-e116
pubmed: 29334124
Nat Genet. 2017 May;49(5):719-729
pubmed: 28346445
Biostatistics. 2010 Jul;11(3):499-514
pubmed: 20212320
Cancer Cell. 2014 Dec 8;26(6):813-825
pubmed: 25490447
Blood. 1991 Feb 15;77(4):687-93
pubmed: 1671560
Bioinformatics. 2014 Aug 15;30(16):2360-6
pubmed: 24794928
Genome Med. 2014 Aug 26;6(8):61
pubmed: 25191524
Oncotarget. 2017 Apr 24;8(31):51946-51962
pubmed: 28881702
Nat Protoc. 2017 Dec;12(12):2478-2492
pubmed: 29120462
Genome Biol. 2013 Sep 24;14(9):r105
pubmed: 24063430
J Clin Oncol. 2017 Mar 20;35(9):975-983
pubmed: 28297628
Blood. 2017 Sep 21;130(12):1395-1401
pubmed: 28778863
Science. 1992 Jul 24;257(5069):531-4
pubmed: 1386162

Auteurs

Michael A Koldobskiy (MA)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Garrett Jenkinson (G)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Whitaker Biomedical Engineering Institute, Johns Hopkins University, Baltimore, MD, USA.
Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.

Jordi Abante (J)

Whitaker Biomedical Engineering Institute, Johns Hopkins University, Baltimore, MD, USA.

Varenka A Rodriguez DiBlasi (VA)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim, Ridgefield, CT, USA.

Weiqiang Zhou (W)

Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Elisabet Pujadas (E)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Adrian Idrizi (A)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Rakel Tryggvadottir (R)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Colin Callahan (C)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Challice L Bonifant (CL)

Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Karen R Rabin (KR)

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.

Patrick A Brown (PA)

Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Hongkai Ji (H)

Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

John Goutsias (J)

Whitaker Biomedical Engineering Institute, Johns Hopkins University, Baltimore, MD, USA. goutsias@jhu.edu.

Andrew P Feinberg (AP)

Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. afeinberg@jhu.edu.
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA. afeinberg@jhu.edu.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. afeinberg@jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH